BackTargeted Medical Pharma Overview

Targeted Medical Pharma EBIT

Track Targeted Medical Pharma's EBIT ($-1.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$366.85K
↑ 67.14% YoY

As of Dec 31, 2015

Annual EBIT (TTM)

-$1.89M
↑ 28.43% YoY

Trailing 12 months ending Dec 31, 2015

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Targeted Medical Pharma (TRGM) FAQ

Targeted Medical Pharma (TRGM) currently reports a EBIT of $-1.9M as of December 2015. That compares with $-2.6M in the prior-year period — up 28.4% year over year. That is below the sector sector average of $2.3T. Use the charts on this page to explore Targeted Medical Pharma's EBIT history and peer comparisons.

Targeted Medical Pharma's EBIT increased from $-2.6M to $-1.9M — a 28.4% year-over-year increase (period ending December 2015). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Targeted Medical Pharma's EBIT of $-1.9M is lower than the its sector sector average of $2.3T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Targeted Medical Pharma reported $-1.9M in EBIT as of December 2015. That compares with $-2.6M in the prior-year period — up 28.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-1.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.3T. From there, open related valuation or income-statement pages for Targeted Medical Pharma, and consider following TRGM for alerts when major investors trade the stock.

Questions & Answers